Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
BMJ (Clinical Research Ed.)
|
February 24, 2018
Improving animal research: PREPARE before you ARRIVE
Adrian J Smith, R Eddie Clutton, Elliot Lilley, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
November 3, 2023
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities
Elliot Lilley, Martijn Bruysters, Pradip Das, et al.
Clinical Science (London, England : 1979)
|
July 11, 2020
Rethinking animal models of sepsis - working towards improved clinical translation whilst integrating the 3Rs
Manasi Nandi, Simon K Jackson, Duncan Macrae, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
November 14, 2022
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of vaccines and biological therapeutics manufacturers
Elliot Lilley, Emmanuelle Coppens, Pradip Das, et al.
Animal Models and Experimental Medicine
|
May 12, 2026
Animal research in the UK: Regulation, implementation, welfare and development of new approach methodologies
Ewan St John Smith, James Bussell, Maggie Gentry, et al.
Inflammopharmacology
|
July 15, 2015
Applying refinement to the use of mice and rats in rheumatoid arthritis research
Penny Hawkins, Rachel Armstrong, Tania Boden, et al.
Journal of Pharmacological and Toxicological Methods
|
January 30, 2013
Reducing suffering in experimental autoimmune encephalomyelitis (EAE)
Sarah Wolfensohn, Penny Hawkins, Elliot Lilley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 9, 2012
7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity
Mark S Nash, Peter McIntyre, Alex Groarke, et al.
Journal of Pharmacological and Toxicological Methods
|
September 25, 2012
Reducing suffering in animal models and procedures involving seizures, convulsions and epilepsy
Sarah Wolfensohn, Penny Hawkins, Elliot Lilley, et al.
Neurogastroenterology and Motility
|
November 5, 2011
Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport
Robert P Watson, Elliot Lilley, Moh Panesar, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
BMJ (Clinical Research Ed.)
|
February 24, 2018
Improving animal research: PREPARE before you ARRIVE
Adrian J Smith, R Eddie Clutton, Elliot Lilley, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
November 3, 2023
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities
Elliot Lilley, Martijn Bruysters, Pradip Das, et al.
Clinical Science (London, England : 1979)
|
July 11, 2020
Rethinking animal models of sepsis - working towards improved clinical translation whilst integrating the 3Rs
Manasi Nandi, Simon K Jackson, Duncan Macrae, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
November 14, 2022
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of vaccines and biological therapeutics manufacturers
Elliot Lilley, Emmanuelle Coppens, Pradip Das, et al.
Animal Models and Experimental Medicine
|
May 12, 2026
Animal research in the UK: Regulation, implementation, welfare and development of new approach methodologies
Ewan St John Smith, James Bussell, Maggie Gentry, et al.
Inflammopharmacology
|
July 15, 2015
Applying refinement to the use of mice and rats in rheumatoid arthritis research
Penny Hawkins, Rachel Armstrong, Tania Boden, et al.
Journal of Pharmacological and Toxicological Methods
|
January 30, 2013
Reducing suffering in experimental autoimmune encephalomyelitis (EAE)
Sarah Wolfensohn, Penny Hawkins, Elliot Lilley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 9, 2012
7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity
Mark S Nash, Peter McIntyre, Alex Groarke, et al.
Journal of Pharmacological and Toxicological Methods
|
September 25, 2012
Reducing suffering in animal models and procedures involving seizures, convulsions and epilepsy
Sarah Wolfensohn, Penny Hawkins, Elliot Lilley, et al.
Neurogastroenterology and Motility
|
November 5, 2011
Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport
Robert P Watson, Elliot Lilley, Moh Panesar, et al.
Page
of 3